Bisacodyl Suppository Dosing in Adults
The recommended adult dose of bisacodyl suppository is 10 mg administered rectally once daily for short-term or rescue relief of constipation. 11
Standard Dosing Regimen
- Administer one 10 mg bisacodyl suppository rectally once daily 11
- Insert the suppository well into the rectum, pointed end first, and retain for approximately 15–20 minutes 1
- Expect bowel movement within 30–60 minutes of insertion 223
Duration and Therapeutic Intent
- Use bisacodyl suppositories only for short-term or rescue therapy, not for chronic daily management 223
- Long-term effectiveness has not been established in controlled trials 22
- Side effects (diarrhea and abdominal pain) are most common during the first week of treatment 22
Mechanism and Onset of Action
- The suppository formulation acts locally in the rectum through direct mucosal contact, initiating its laxative effect without requiring significant systemic absorption 45
- Bisacodyl is converted by mucosal deacetylase enzymes to the active metabolite BHPM (bis-(p-hydroxyphenyl)-pyridyl-2-methane), which directly stimulates colonic peristalsis and fluid secretion 223
- The rapid 30–60 minute onset with rectal administration contrasts sharply with the 6–12 hour delay seen with oral tablets 223
Absolute Contraindications
Do not use bisacodyl suppositories in patients with: 223
- Ileus or intestinal obstruction
- Severe dehydration
- Acute inflammatory bowel disease
Common Pitfalls and Clinical Considerations
- Antibiotic therapy may reduce efficacy because antibiotics alter gut flora needed to convert bisacodyl to its active metabolite 223
- Prolonged or excessive use can cause diarrhea and electrolyte disturbances 3
- The rectal formulation produces minimal systemic absorption (plasma levels often below detection limits in many patients), with only approximately 3.4% excreted in urine, confirming predominantly local action 4
- There is no relationship between plasma levels and laxative effect with suppository use, as the drug acts directly at the rectal mucosa 45
Comparison to Oral Formulation
- While oral bisacodyl is typically initiated at 5 mg daily (not 10 mg) to minimize adverse effects in clinical practice 223, the rectal suppository standard dose remains 10 mg 11
- The suppository formulation avoids the high systemic adverse effect rates (53% diarrhea, 25% abdominal pain) seen with 10 mg oral dosing because of its local mechanism of action 22